Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tumor total lesion glycolysis and number of positive pelvic lymph nodes on pretreatment positron emission tomography/computed tomography (PET/CT) predict survival in patients with locally advanced cervical cancer.
De Cuypere M, Lovinfosse P, Gennigens C, Hermesse J, Rovira R, Duch J, Goffin F, Hustinx R, Kridelka F. De Cuypere M, et al. Among authors: gennigens c. Int J Gynecol Cancer. 2020 Nov;30(11):1705-1712. doi: 10.1136/ijgc-2020-001676. Epub 2020 Oct 8. Int J Gynecol Cancer. 2020. PMID: 33033165
Clinical efficacy and toxicity of radio-chemotherapy and magnetic resonance imaging-guided brachytherapy for locally advanced cervical cancer patients: A mono-institutional experience.
Lakosi F, de Cuypere M, Viet Nguyen P, Jansen N, Warlimont B, Gulyban A, Gennigens C, Seidel L, Delbecque K, Coucke P, Hermesse J, Kridelka F. Lakosi F, et al. Among authors: gennigens c. Acta Oncol. 2015;54(9):1558-66. doi: 10.3109/0284186X.2015.1062542. Epub 2015 Sep 25. Acta Oncol. 2015. PMID: 26406152
Added value of para-aortic surgical staging compared to 18F-FDG PET/CT on the external beam radiation field for patients with locally advanced cervical cancer: An ONCO-GF study.
De Cuypere M, Lovinfosse P, Goffin F, Gennigens C, Rovira R, Duch J, Fastrez M, Gebhart G, Squifflet JL, Luyckx M, Charaf G, Crener K, Buxant F, Bucella D, Jouret M, Hustinx R, Kridelka F. De Cuypere M, et al. Among authors: gennigens c. Eur J Surg Oncol. 2020 May;46(5):883-887. doi: 10.1016/j.ejso.2019.11.496. Epub 2019 Nov 11. Eur J Surg Oncol. 2020. PMID: 31784203
Optimal treatment in locally advanced cervical cancer.
Gennigens C, De Cuypere M, Hermesse J, Kridelka F, Jerusalem G. Gennigens C, et al. Expert Rev Anticancer Ther. 2021 Jun;21(6):657-671. doi: 10.1080/14737140.2021.1879646. Epub 2021 Mar 11. Expert Rev Anticancer Ther. 2021. PMID: 33472018 Free article. Review.
[Locally-advanced cervix cancer : multidisciplinary management].
Lapaille L, De Cuypere M, Goffin F, Kakkos A, Gonne E, Hermesse J, Lovinfosse P, Delbecque K, Thille A, Kridelka F, Gennigens C. Lapaille L, et al. Among authors: gennigens c. Rev Med Liege. 2021 May;76(5-6):507-514. Rev Med Liege. 2021. PMID: 34080388 Free article. French.
Diagnostic Performance of Immunohistochemistry Compared to Molecular Techniques for Microsatellite Instability and p53 Mutation Detection in Endometrial Cancer.
Streel S, Salmon A, Dheur A, Bours V, Leroi N, Habran L, Delbecque K, Goffin F, Pleyers C, Kakkos A, Gonne E, Seidel L, Kridelka F, Gennigens C. Streel S, et al. Among authors: gennigens c. Int J Mol Sci. 2023 Mar 2;24(5):4866. doi: 10.3390/ijms24054866. Int J Mol Sci. 2023. PMID: 36902292 Free PMC article.
Prospective non-interventional BELOVA/BGOG-ov16 study on safety of frontline bevacizumab in elderly patients with FIGO stage IV ovarian cancer: a study of the Belgian and Luxembourg Gynaecological Oncology Group.
Vergote I, Van Nieuwenhuysen E, De Waele S, Vulsteke C, Lamot C, Van den Bulck H, Claes N, Graas MP, Debrock G, Spoormans I, Vuylsteke P, Honhon B, Verhoeven D, De Maeseneer D, Dirix L, Mebis J, Vroman P, Denys H, Martinez Mena C, Pelgrims G, Van Steenberghe M, van Gorp T, Gennigens C. Vergote I, et al. Among authors: gennigens c. Int J Gynecol Cancer. 2022 Jun 6;32(6):753-760. doi: 10.1136/ijgc-2021-003190. Int J Gynecol Cancer. 2022. PMID: 35063943 Clinical Trial.
56 results